Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Shares Sold by Gladius Capital Management LP

Gladius Capital Management LP trimmed its position in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 39.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,158 shares of the company’s stock after selling 2,704 shares during the quarter. Gladius Capital Management LP’s holdings in Nature’s Sunshine Products were worth $57,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Skylands Capital LLC increased its holdings in Nature’s Sunshine Products by 722.1% in the second quarter. Skylands Capital LLC now owns 333,101 shares of the company’s stock valued at $5,020,000 after buying an additional 292,581 shares in the last quarter. Paradigm Capital Management Inc. NY grew its position in shares of Nature’s Sunshine Products by 26.8% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock valued at $10,475,000 after acquiring an additional 146,879 shares during the period. American Century Companies Inc. increased its stake in shares of Nature’s Sunshine Products by 25.7% in the 2nd quarter. American Century Companies Inc. now owns 260,479 shares of the company’s stock valued at $3,925,000 after purchasing an additional 53,221 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Nature’s Sunshine Products by 4.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 786,966 shares of the company’s stock worth $11,860,000 after purchasing an additional 34,996 shares during the period. Finally, Bailard Inc. purchased a new position in Nature’s Sunshine Products during the second quarter worth approximately $197,000. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Canaccord Genuity Group initiated coverage on Nature’s Sunshine Products in a research report on Friday, September 13th. They issued a “buy” rating and a $18.00 price objective for the company. DA Davidson reduced their price objective on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, August 12th. Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a research report on Friday, September 13th. They issued a “buy” rating and a $18.00 target price on the stock. Finally, StockNews.com upgraded shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 10th.

Nature’s Sunshine Products Stock Performance

Shares of NATR stock opened at $16.00 on Friday. Nature’s Sunshine Products, Inc. has a fifty-two week low of $10.81 and a fifty-two week high of $21.72. The stock’s fifty day moving average is $13.64 and its two-hundred day moving average is $14.61. The firm has a market capitalization of $295.68 million, a P/E ratio of 18.18 and a beta of 0.87.

Insider Activity

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, October 10th. The stock was sold at an average price of $13.39, for a total value of $40,170.00. Following the completion of the sale, the insider now directly owns 69,347 shares in the company, valued at $928,556.33. This represents a 4.15 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders sold 7,499 shares of company stock worth $99,802 over the last three months. Insiders own 4.70% of the company’s stock.

Nature’s Sunshine Products Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.